746 articles in this topic
A Cochrane meta-analysis of 17 RCTs finds amyloid-targeting antibodies offer minimal cognitive gains while significantly raising ARIA risk.
A 10-year Swiss cohort study finds chronic subdural hematoma surgery patients suffer sustained excess mortality and significant cognitive and functional impairments.
A 58-year-old man's red, bulging eye turned out to be a cavernous sinus dural arteriovenous fistula β a rare but treatable vascular condition.
First 6-month RCT shows PAP therapy meaningfully improves MoCA scores and motor function in Parkinson's patients with OSA.
New JAMA Neurology analysis reveals that chronic subdural hematoma carries significant long-term neurological effects that extend far beyond the risk of bleeding recurrence.
Stanford researchers find pioglitazone and liraglutide improve CNS insulin signaling, measured via neuron-derived vesicles in blood.
A GeneReviews update details how activating MTOR variants cause a rare overgrowth-intellectual disability syndrome, with early rapamycin trials showing promise.
A landmark multi-omic atlas of 100 GBM patients uncovers four malignant cellular communities and new therapeutic targets.
Huberman breaks down the neuroscience of memory formation and shares actionable protocols using adrenaline, sleep, exercise, and brief meditation.
New research reveals how amyloid-Ξ² triggers a calcium-cholesterol cascade in brain cells that clogs the glymphatic system β and how statins may reverse it.
Go beyond the basics and explore the molecular machinery behind glymphatic flow, AQP4 water channels, meningeal lymphatics, and why their dysfunction drives neurodegeneration.
Discover how your brain flushes out toxic waste while you sleep β and why this nightly cleanup is one of the most important things you can do for long-term brain health.
